Scientific Publications

08.05.2014

Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency

Muik, A., Stubbert, L.J., Jahedi, R.Z., Geiß, Y., Dold, C., Tober, R., Volk, A., Klein, S., Dietrich, U., Yadollahi, U., Falls, T., Miletic, H., Stojdl, D., Bell, J.C. & von Laer, D. A highly potent chimeric oncolytic virus for the treatment of brain cancer. Cancer Res, 74(13):3567-78 (2014)

19.02.2014

VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications

Tober, R., Banki, Z., Egerer, L., Muik, A., Behmüller, S., Kreppel, F., Greczmiel, U., Oxenius, A., von Laer, D. & Kimpel, J. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications. J Virol, 88(9):4897-907 (2014)

28.02.2012

Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy

Muik, A., Dold, C., Geiß, Y., Volk, A., Werbizki, M., Dietrich, U. & von Laer, D. Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy. J Mol Med (Berl), 90(8):959-70 (2012)

30.03.2011

Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism

Muik, A., Kneiske, I., Werbizki, M., Wilflingseder, D., Giroglou, T., Ebert, O., Kraft, A., Dietrich, U., Zimmer, G., Momma, S. & von Laer, D. Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J Virol, 85(11):5679-84 (2011)